|
Real-time Estimate
Cboe BZX
10:24:06 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 2.415 USD | -0.21% |
|
+22.36% | -36.09% |
| 09-29 | Larimar Therapeutics Names John Harlow COO | MT |
| 09-28 | Larimar Therapeutics, Inc. Announces Appointment of John Harlow as President and Chief Operating Officer, Effective September 29, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.21% | +22.36% | -36.26% | -39.43% | -36.09% | -38.04% | -13.65% | -80.96% | - | 253M | |
| -0.21% | -4.43% | -12.27% | +16.53% | +62.57% | +44.40% | +74.13% | +4.36% | - | 66.22B | |
| +1.17% | +4.90% | -6.97% | +4.93% | +11.02% | +12.21% | +76.49% | +218.83% | +5,492.41% | 55.2B | |
| +0.95% | +4.41% | +12.01% | +17.52% | +17.22% | +12.57% | +92.43% | -16.50% | +248.87% | 52.79B | |
| +0.46% | +2.47% | +2.83% | +39.90% | +23.21% | +27.48% | +51.18% | +8.11% | +272.59% | 45.53B | |
| -1.64% | +2.02% | +3.68% | +19.29% | +25.61% | +21.72% | +126.18% | +0.73% | +1,051.57% | 43.94B | |
| -2.41% | +1.32% | -0.58% | +4.76% | +140.74% | +261.93% | +944.67% | +602.38% | - | 41.64B | |
| +0.10% | +9.90% | +8.93% | +15.15% | +14.63% | +16.11% | +59.33% | +10.50% | +165.28% | 34B | |
| -8.38% | -6.95% | -14.04% | +16.53% | +43.96% | +26.35% | -1.93% | -60.05% | - | 25.84B | |
| +1.26% | +5.10% | +16.63% | +39.09% | +31.13% | +38.44% | +28.22% | -11.13% | +132.34% | 23.51B | |
| +0.56% | +2.44% | -8.40% | +0.62% | -2.94% | -13.02% | -0.13% | -66.80% | - | 22.93B | |
| +0.12% | -4.19% | -21.33% | -10.87% | -45.39% | -40.74% | +281.73% | +246.27% | +575.55% | 20.54B | |
| -0.16% | +5.00% | +4.73% | +24.97% | +17.51% | +20.72% | +190.09% | +252.87% | +2,022.90% | 18.49B | |
| +0.17% | +3.42% | +11.75% | +18.19% | +48.25% | +80.10% | +237.56% | +203.64% | +475.55% | 16B | |
| +2.13% | +4.37% | +4.64% | +17.06% | +32.40% | +30.98% | +75.23% | -19.71% | +92.97% | 15.76B | |
| -0.07% | +6.35% | +1.44% | -4.34% | - | - | - | - | - | 15.69B | |
| +0.35% | +14.09% | +22.55% | +59.76% | +75.16% | +86.84% | +92.77% | -16.93% | +321.88% | 16.46B | |
| +1.73% | -1.26% | +2.17% | 0.00% | +177.32% | +151.62% | +366.59% | +1,443.68% | +750.84% | 15.01B | |
| -5.37% | +2.14% | -8.65% | -13.38% | +14.18% | -1.24% | +521.51% | - | - | 14.41B | |
| +0.77% | +6.70% | +11.82% | +11.70% | +2.54% | -2.98% | -16.14% | -32.67% | +119.73% | 14.29B | |
| Average | -0.46% | +4.75% | -0.27% | +11.90% | +34.37% | +38.71% | +167.70% | +149.26% | +901.73% | 27.93B | |
| Weighted average by Cap. | -0.41% | +3.81% | +0.38% | +15.59% | +38.33% | +44.54% | +170.31% | +127.89% | +1,238.84% |
- Stock Market
- Stocks
- LRMR Stock
- Sector Larimar Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
